AEKYUNG CHEMICAL Corrects Stock Option Grant Downward - Reduction from 50,305 to 25,537 Shares, Easing Potential Dilution

AEKYUNG CHEMICAL filed a correction to its 2022 stock option grant, significantly reducing the scale from 50,305 shares to 11 grantees to 25,537 shares to 8 grantees.
The correction cancels options for the CEO and two other executives, lowering potential dilution for existing shareholders.
Total outstanding options after correction are 190,019 shares (0.39% of total outstanding shares). The exercise price of 11,338 won is below the current market price of 12,850 won, but the reduction mitigates dilution risk.
[AI Summary]The downward revision of stock option grants is a mild positive for shareholders, reducing potential dilution and signaling prudent management of equity incentives.